BIOLASE, Inc. (BIOL)

BIOLASE Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	48.83	49.16	48.46	39.19	22.78	37.8
Revenue Growth (YoY)	0.13%	1.45%	23.67%	72.03%	-39.73%	-18.10%
Cost of Revenue	32.1	32.44	32.55	22.66	16.61	23.51
Gross Profit	16.72	16.72	15.91	16.53	6.17	14.29
Selling, General & Admin	28.15	28.66	33.98	26.6	21.01	25.14
Research & Development	5.74	6	7.27	6.05	3.7	4.77
Other Operating Expenses	-1.17	0.05	0	0	4.22	0
Operating Expenses	33.9	34.66	41.25	32.65	24.71	29.91
Operating Income	-17.17	-17.94	-25.34	-16.12	-18.54	-15.62
Interest Income	-0.58	0	2.75	2.22	2.36	2.16
Interest Expense	2.41	2.36	2.75	2.22	2.36	2.16
Other Expense / Income	1.06	0.3	3.19	-0.02	-1.84	2.28
Pretax Income	-21.22	-20.6	-28.53	-16.09	-16.7	-17.9
Income Tax	0.05	0.03	0.11	0.07	0.13	-0.04
Net Income	-21.27	-20.63	-28.63	-16.16	-16.83	-17.86
Shares Outstanding (Basic)	18	1	0	0	0	0
Shares Outstanding (Diluted)	18	1	0	0	0	0
Shares Change	5338.64%	1744.16%	17.26%	141.67%	163.50%	12.69%
EPS (Basic)	-14.94	-16.14	-413.19	-273.41	-688.19	-1923.95
EPS (Diluted)	-14.94	-16.14	-413.19	-273.41	-688.19	-1923.95
Free Cash Flow	-15.07	-15.4	-30.49	-17.42	-12.89	-12.95
Free Cash Flow Per Share	-0.84	-12.05	-439.94	-294.71	-527.15	-1395.74
Gross Margin	34.25%	34.02%	32.83%	42.18%	27.10%	37.80%
Operating Margin	-35.17%	-36.48%	-52.28%	-41.12%	-81.37%	-41.33%
Profit Margin	-43.56%	-41.97%	-59.09%	-41.23%	-73.88%	-47.24%
Free Cash Flow Margin	-30.86%	-31.33%	-62.91%	-44.44%	-56.59%	-34.27%
EBITDA	-14.54	-15.14	-24.84	-15.72	-13.82	-14.64
EBITDA Margin	-29.78%	-30.79%	-51.26%	-40.10%	-60.68%	-38.73%
Depreciation & Amortization	3.31	2.8	0.5	0.4	0.5	0.98
EBIT	-17.85	-17.94	-25.34	-16.12	-14.32	-15.62
EBIT Margin	-36.56%	-36.48%	-52.28%	-41.12%	-62.87%	-41.33%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.